- Home
- KE vs EVMN Comparison
KE vs EVMN Comparison
Compare KE & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KE | EVMN |
|---|---|---|
| Founded | 1961 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 738.4M | 628.9M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | KE | EVMN |
|---|---|---|
| Price | $30.55 | $21.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $28.00 | ★ $38.60 |
| AVG Volume (30 Days) | 166.3K | ★ 333.9K |
| Earning Date | 02-03-2026 | 02-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.88 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $1,478,074,000.00 | $13,000,000.00 |
| Revenue This Year | N/A | $89.43 |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | $31.13 | ★ N/A |
| Revenue Growth | N/A | ★ 160.00 |
| 52 Week Low | $12.41 | $13.89 |
| 52 Week High | $33.19 | $24.03 |
Technical Indicators
Market Signals| Indicator | KE | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 60.75 | N/A |
| Support Level | $28.15 | N/A |
| Resistance Level | $30.00 | N/A |
| Average True Range (ATR) | 0.95 | 0.00 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 95.08 | 0.00 |
Price Performance
Historical ComparisonAbout KE Kimball Electronics Inc.
Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.